Christophe Massard

2004–2026 年に発表

161: 論文数
22,018: 被引用数
79: h 指数
156: i10 指数

被引用数

引用元

国・地域

0%22.9%その他 21.3%

機関

分野

トピック

全論文

並び替え

検索で開く

A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
著者: Roger Sun, Elaine Johanna Limkin, Maria Vakalopoulou, Laurent Dercle, Stéphane Champiat, Shan Rong Han, Loïc Verlingue, David Brandão, Andrea Lancia, Samy Ammari, Antoine Hollebecque, Jean‐Yves Scoazec, Aurélien Marabelle, Christophe Massard, Jean‐Charles Soria, Charlotte Robert, Nikos Paragios, Éric Deutsch, Charles Ferté - The Lancet Oncology 2018 被引用: 1,230
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
著者: Jean‐Marie Michot, Camille Bigenwald, Stéphane Champiat, Michael Collins, Franck Carbonnel, Sophie Postel‐Vinay, A. Berdelou, Andreea Varga, Rastislav Bahleda, Antoine Hollebecque, Christophe Massard, Alina Fuerea, Vincent Ribrag, Anas Gazzah, Jean‐Pierre Armand, Nadia Amellal, Eric Angevin, Nicolas Noël, C. Boutros, Christine Mateus, Caroline Robert, Jean‐Charles Soria, Aurélien Marabelle, Olivier Lambotte - European Journal of Cancer 2016 被引用: 2,129
High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
著者: Christophe Massard, Stefan Michiels, Charles Ferté, Marie‐Cécile Le Deley, Ludovic Lacroix, Antoine Hollebecque, Loïc Verlingue, Ecaterina Ileana, Silvia Rosellini, Samy Ammari, Maud Ngo‐Camus, Rastislav Bahleda, Anas Gazzah, Andrea Varga, Sophie Postel‐Vinay, Yohann Loriot, Caroline Even, Ingrid Breuskin, Nathalie Auger, Bastien Job, Thierry de Baère, Frédèric Deschamps, Philippe Vielh, Jean‐Yves Scoazec, Vladimir Lazar, Catherine Richon, Vincent Ribrag, Éric Deutsch, Eric Angevin, Gilles Vassal, Alexander M.M. Eggermont, Fabrice André, Jean‐Charles Soria - Cancer Discovery 2017 被引用: 776
Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial
著者: Christopher J. Sweeney, Sergio Bracarda, Cora N. Sternberg, Kim N., David Olmos, Shahneen Sandhu, Christophe Massard, Nobuaki Matsubara, B. Yа. Alekseev, Francis Parnis, Vagif Atduev, Gary L. Buchschacher, Rustem Gafanov, Luis Corrales, Michael Borre, Daniil Stroyakovskiy, Gustavo Vasconcelos Alves, Evangelos Bournakis, Javier Puente, Marie-Laurence Harle-Yge, Jorge D. Gallo, Geng Chen, Justin Hanover, Matthew Wongchenko, Josep Garcia, Johann S. de Bono - The Lancet 2021 被引用: 329
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
著者: Shubham Pant, Martin Schüler, Gopa Iyer, Olaf Witt, Toshihiko Doi, Toshihiko Doi, Josep Tabernero, David A. Reardon, Christophe Massard, Anna Minchom, Iwona Ługowska, Omar Carranza, Dirk Arnold, Martin Gutierrez, Helen Winter, Kim Stuyckens, Lauren Crow, Saltanat Najmi, Constance Hammond, Shibu Thomas, Ademi Santiago-Walker, Spyros Triantos, Hussein Sweiti, Yohann Loriot, Omar Carranza, Martin Alberto Greco, Omar Carranza, Anthony M. Joshua, Christos S. Karapetis, Christopher D. Hart, Alison Y. Zhang, Hans Prenen, Jean‐Charles Goeminne, Jean‐Pascal Machiels, Sylvie Rottey, Marcelo Corassa, Graziela Zibetti Dal Molin, Katsuki Arima Tiscoski, Denis L. Jardim, Milena Perez Mak, Wei Fu, Herui Yao, Jing Huang, Haiping Jiang, Jing Huang, Baoshi Chen, Dong Yan, Yu Yang, Yohann Loriot, Christophe Le Tourneau, Nicolas Penel, Sébastien Salas, Jean‐Yves Blay, Pierre-Emmanuel Brachet, Xavier Durando, Sheik Emambux, Alain Ravaud, Gunnar Folprecht, Dirk Arnold, Martin Schüler, Marit Ahrens, Alexander Golf, Georg Martin Haag, Florian Lordick, Alexander Desuki, Marina Elena Cazzaniga, Fortunato Ciardiello, Michèle Milella, Takafumi Koyama, Yoshiki Hirooka, Wataru Okamoto, Kenjiro Aogi, Yasutoshi Kuboki, Jung-Yun Lee, Sung‐Bae Kim, Myung‐Ju Ahn, Jong Hee Chang, Yongman Kim, Do‐Hyun Nam, Jaesung Park, Iwona Ługowska, Luis Paz‐Ares, Víctor Moreno, Andrés Cervantes, Mariona Calvo, Alejandro Falcón, Antonio González, Josep Tabernero, A. Martinez Bueno, Javier García-Corbacho, Federico Longo, Chia‐Jui Yen, Jen‐Shi Chen, Ming‐Feng Hou, Yee Chao, Kun‐Ming Rau, Tai‐Jan Chiu, Yin‐Hsun Feng, Chih‐Hung Hsu, Wen‐Tsung Huang ほか 33 名 - The Lancet Oncology 2023 被引用: 200
Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1
著者: Stéphane Champiat, Laurent Dercle, Samy Ammari, Christophe Massard, Antoine Hollebecque, Sophie Postel‐Vinay, Nathalie Chaput, Alexander M.M. Eggermont, Aurélien Marabelle, Jean‐Charles Soria, Charles Ferté - Clinical Cancer Research 2016 被引用: 1,197
Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study
著者: Aaron R. Hansen, Christophe Massard, Patrick A. Ott, Naomi B. Haas, Juanita Lopez, Samuel Ejadi, John M. Wallmark, Bhumsuk Keam, Jean‐Pierre Delord, Rahul Aggarwal, M. Gould, Peng Yang, Stephen J. O’Keefe, Sarina A. Piha‐Paul - Annals of Oncology 2018 被引用: 367
CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17
著者: Stéphanie Corgnac, Ines Malenica, Laura Mezquita, Édouard Auclin, Elodie Voilin, Jamila Kacher, Heloise M. Halse, Laetitia Grynszpan, Nicolas Signolle, Thibault Dayris, Marine Leclerc, Nathalie Droin, Vincent de Montpréville, Olaf Mercier, Pierre Validire, Jean‐Yves Scoazec, Christophe Massard, Salem Chouaı̈b, David Planchard, Julien Adam, Benjamin Besse, Fathia Mami‐Chouaib - Cell Reports Medicine 2020 被引用: 194
Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer
著者: Audrey Simonaggio, Jean‐Marie Michot, Anne Laure Voisin, Jérôme Le Pavec, Michael Collins, A. Lallart, Geoffray Cengizalp, Aurore Vozy, Ariane Laparra, Andréa Varga, Antoine Hollebecque, Stéphane Champiat, Aurélien Marabelle, Christophe Massard, Olivier Lambotte - JAMA Oncology 2019 被引用: 372
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma
著者: Thomas Powles, Peter H. O’Donnell, Christophe Massard, Hendrik-Tobias Arkenau, Terence W. Friedlander, Christopher Hoimes, Jae‐Lyun Lee, Michael Ong, Srikala S. Sridhar, Nicholas J. Vogelzang, Mayer Fishman, Jingsong Zhang, Sandy Srinivas, Jigar Parikh, Joyce Antal, Xiaoping Jin, Ashok Gupta, Yong Ben, Noah M. Hahn - JAMA Oncology 2017 被引用: 846
The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology
著者: David Tamborero, Rodrigo Dienstmann, Maan Haj Rachid, Jorrit Boekel, Adrià López‐Fernández, Markus Jonsson, Ali Razzak, Irene Braña, Luigi De Petris, Jeffrey Yachnin, Richard D. Baird, Yohann Loriot, Christophe Massard, Patricia Martín-Romano, Frans L. Opdam, Richard F. Schlenk, Claudio Vernieri, Michele Masucci, Xenia Villalobos, Elena Chavarria, Shubha Anand, Danny Baars, Svetlana Bajalica‐Lagercrantz, Richard D. Baird, Mariska Bierkens, Lennart Blomqvist, Costanza Bono, Luigi De Petris, Gary J. Doherty, A Forest, Valentina Fornerone, Paola Gabaldi, Felix Haglund, Johan Hartman, Peter Horak, Tanja Jutzi, Mary Kasanicki, Simon Kreutzfeldt, Lucian Le Cornet, Rolf Lewensohn, Johan Lindberg, Carlos López, Andreas Lundqvist, Jose‐Ezequiel Martín, Gerrit A. Meijer, Susana Muñoz, Maud Ngo Camus, Claudio Nicotra, Paolo Nucíforo, Petra Oberrauch, Päivi Östling, Laura Pelz, Alejandro Piris‐Giménez, Elena Provenzano, Étienne Rouleau, John Rowell, Omar Saavedra, Giovanni Scoazec, Kenneth B. Seamon, Marc Tischkowitz, Lizet van der Kolk, Ruud van der Noll, María Vieito, Daniël J. Vis, Ana Vivancos, Christina von Gertten, Anders Wennborg, Lodewyk F.A. Wessels, Valtteri Wirta, Judith Balmañà, Giovanni Apolone, Carlos Caldas, Jonas Bergh, Ingemar Ernberg, Stefan Fröhling, Elena Garralda, Claes Karlsson, Josep Tabernero, Emile E. Voest, Jordi Rodón, Janne Lehtiö - Nature Cancer 2022 被引用: 130
Treatment with pembrolizumab in programmed death ligand 1–positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE‐028 trial
著者: David A. Reardon, Tae Min Kim, Jean‐Sébastien Frenel, Matteo Simonelli, Juanita Lopez, Deepa S. Subramaniam, Lillian L. Siu, Hui Wang, Suba Krishnan, Karen Stein, Christophe Massard - Cancer 2021 被引用: 121
Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance
著者: Yohann Loriot, Aurélien Marabelle, Jean‐Philippe Guégan, François‐Xavier Danlos, Benjamin Besse, Nathalie Chaput, Christophe Massard, David Planchard, Caroline Robert, Caroline Even, Mohamed Khettab, Lambros Tselikas, Luc Friboulet, Fabrice André, Imane Nafia, François Le Loarer, Jean‐Charles Soria, Alban Bessede, Antoîne Italiano - Annals of Oncology 2021 被引用: 87
Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors
著者: Jeremy Lewin, Jean‐Charles Soria, Anastasios Stathis, Jean‐Pierre Delord, Solange Peters, Ahmad Awada, Philippe Aftimos, Mohamed Békradda, Keyvan Rezaï, Zhen Zeng, Azher Hussain, Susan Perez, Lillian L. Siu, Christophe Massard - Journal of Clinical Oncology 2018 被引用: 280
Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss
著者: Johann S. de Bono, Ugo De Giorgi, Daniel Nava Rodrigues, Christophe Massard, Sergio Bracarda, Albert Font, Jóse Ángel Arranz Arija, Kent C. Shih, George Daniel Rădăvoi, Na Xu, Wai Yee Chan, Han Ma, Steven Gendreau, Ruth Riisnaes, Premal H. Patel, Daniel Maslyar, Viorel Jinga - Clinical Cancer Research 2018 被引用: 310
Intratumoral Immunotherapy: From Trial Design to Clinical Practice
著者: Stéphane Champiat, Lambros Tselikas, Siham Farhane, Thibault Raoult, Matthieu Texier, Émilie Lanoy, Christophe Massard, Caroline Robert, Samy Ammari, Thierry de Baère, Aurélien Marabelle - Clinical Cancer Research 2020 被引用: 135
Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease
著者: François‐Xavier Danlos, Anne-Laure Voisin, Valérie Dyevre, Jean‐Marie Michot, Émilie Routier, Laurent Taillade, Stéphane Champiat, Sandrine Aspeslagh, Julien Haroche, Laurence Albigès, Christophe Massard, Nicolas Girard, Stéphane Dalle, Benjamin Besse, Salim Laghouati, Jean‐Charles Soria, Christine Mateus, Caroline Robert, Émilie Lanoy, Aurélien Marabelle, Olivier Lambotte - European Journal of Cancer 2018 被引用: 311
Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial
著者: Jean‐Yves Blay, Sylvie Chevret, Axel Le Cesne, Mehdi Brahmi, Nicolas Penel, Sophie Cousin, François Bertucci, Emmanuelle Bompas, Thomas Ryckewaert, Pauline Soibinet, Pascaline Boudou‐Rouquette, Esma Saada Bouzid, P Soulié, Thibaud Valentin, Jean‐Pierre Lotz, Diégo Tosi, Zoé Nevière, Mathilde Cancel, Isabelle Ray‐Coquard, Laëtitia Gambotti, Frédéric Legrand, Assia Lamrani-Ghaouti, Clotilde Simon, Caroline Even, Christophe Massard - The Lancet Oncology 2023 被引用: 88
Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score)
著者: Frédéric Bigot, Eduardo Castañón, Capucine Baldini, Antoine Hollebecque, Alberto Carmona‐Bayonas, Sophie Postel‐Vinay, Eric Angevin, Jean‐Pierre Armand, Vincent Ribrag, Sandrine Aspeslagh, Andréa Varga, Rastislav Bahleda, Jessica Menis, Anas Gazzah, Jean‐Marie Michot, Aurélien Marabelle, Jean‐Charles Soria, Christophe Massard - European Journal of Cancer 2017 被引用: 225
The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry
著者: Valentine Ruste, Vincent Goldschmidt, Ariane Laparra, Sabine Messayke, François‐Xavier Danlos, Patricia Romano‐Martin, Stéphane Champiat, Anne-Laure Voisin, Capucine Baldini, Christophe Massard, Salim Laghouati, Aurélien Marabelle, Olivier Lambotte, Jean‐Marie Michot - European Journal of Cancer 2021 被引用: 83
Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study
著者: Evan Y. Yu, Michael Kolinsky, William L. Berry, Margitta Retz, Loı̈c Mourey, Josep M. Piulats, Leonard J. Appleman, Emanuela Romano, Gwénaëlle Gravis, Howard Gurney, Martin Bögemann, Urban Emmenegger, Anthony M. Joshua, Mark Linch, Srikala S. Sridhar, Henry Jacob Conter, Brigitte Laguerre, Christophe Massard, Xin Tong Li, Charles Schloss, Christian Poehlein, Johann S. de Bono - European Urology 2022 被引用: 79
Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial
著者: Loïc Verlingue, David Malka, Adrien Allorant, Christophe Massard, Charles Ferté, Ludovic Lacroix, Étienne Rouleau, Nathalie Auger, Maud Ngo, Claudio Nicotra, Thierry de Baère, Lambros Tselikas, Bakar Ba, Stefan Michiels, Jean‐Yves Scoazec, Valérie Boige, Michel Ducreux, Jean‐Charles Soria, Antoine Hollebecque - European Journal of Cancer 2017 被引用: 170
Safety and Efficacy of Durvalumab (MEDI4736), an Anti–Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer
著者: Christophe Massard, Michael S. Gordon, Sunil Sharma, Saeed Rafii, Zev A. Wainberg, Jason J. Luke, Tyler J. Curiel, Gerardo Colón‐Otero, Omid Hamid, Rachel E. Sanborn, Peter H. O’Donnell, Alexandra Drakaki, Winston Tan, John F. Kurland, Marlon C. Rebelatto, Xiaoping Jin, John A. Blake-Haskins, Ashok Gupta, Neil H. Segal - Journal of Clinical Oncology 2016 被引用: 845
Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study
著者: Nicolas Delanoy, Jean‐Marie Michot, Thibault Comont, N. Kramkimel, Julien Lazarovici, Romain Dupont, Stéphane Champiat, Claude Chahine, Caroline Robert, Charles Herbaux, Benjamin Besse, Aude Guillemin, Christine Mateus, Patricia Pautier, Philippe Saïag, Emanuela Madonna, Marie Maerevoet, Jean-Christophe Bout, Charlotte Leduc, P. Biscay, Gilles Quéré, Charlée Nardin, Mikaël Ebbo, Laurence Albigès, Grégoire Marret, Virginie Levrat, C. Dujon, Jacques Vargaftig, Salim Laghouati, Laure Croisille, Anne-Laure Voisin, Bertrand Godeau, Christophe Massard, Vincent Ribrag, Aurélien Marabelle, Marc Michel, Olivier Lambotte - The Lancet Haematology 2018 被引用: 292